Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3515LS1M
Performance in the last:
Follow this Portfolio
1D -1.5 %
1W -7.8 %
2W 4.5 %
1M 18.5 %
3M 10.3 %
6M -2.7 %
9M -81.7 %
1Y -78.9 %
Alpha
-101.6%
Beta
0.76
sharpe-R
-0.9
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
2.45
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2024-11-21 08:30:36
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -86.36%
Max. DrawDown Benchmark -8.41%

This Long-Short strategy aims to find promising assets to invest in for a maximum holding period of 1 Month in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 15.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

For Long-Short model portfolios, the short-selling costs (asset borrowing costs) are not taken into account. This assumption is likely unrealistic, and it is important to understand the short-selling process before employing this type of strategy.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
4

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Asset Class Action Weight PnL
CDMO Avid Bioservices, Inc. Equity Buy 12.16% 17.95%
HCSG Healthcare Services Group, Inc. Equity Buy 10.47% 4.02%
NEOG Neogen Corporation Equity Buy 12.17% 3.91%
ITGR Integer Holdings Corporation Equity Buy 28.1% -2.48%
CUTR Cutera, Inc. Equity Sell -2.17% 46.43%
AMPH Amphastar Pharmaceuticals, Inc. Equity Sell -7.29% 4.34%
TNDM Tandem Diabetes Care, Inc. Equity Sell -6.95% 1.47%
KIDS OrthoPediatrics Corp. Equity Sell -7% 0.86%
ENTA Enanta Pharmaceuticals, Inc. Equity Sell -5.79% 17.98%
The percentage of cash held in the portfolio is: 66.29%
** The description of each asset is available Here

The latest 5 Compositions change

2024-11-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDMO Avid Bioservices, Inc. Buy 12.02% 17.66%
HCSG Healthcare Services Group, Inc. Buy 10.36% 3.74%
NEOG Neogen Corporation Buy 12.22% 5.23%
ITGR Integer Holdings Corporation Buy 27.9% -2.37%
CUTR Cutera, Inc. Sell -2.15% 46.43%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.15% 5.36%
TNDM Tandem Diabetes Care, Inc. Sell -6.37% 8.92%
KIDS OrthoPediatrics Corp. Sell -6.62% 5.44%
ENTA Enanta Pharmaceuticals, Inc. Sell -5.95% 14.91%
The percentage of cash held in the portfolio is: 65.74%
New Assets Added
None
Assets Removed
Asset Action Perf %
MGNX Sell All -10.08%
MDRX Sell All -7.2%
Assets Rebalanced
None
2024-11-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDMO Avid Bioservices, Inc. Buy 11.94% 17.18%
HCSG Healthcare Services Group, Inc. Buy 10.49% 5.39%
NEOG Neogen Corporation Buy 11.79% 1.81%
MGNX MacroGenics, Inc. Buy 9.2% -7.75%
ITGR Integer Holdings Corporation Buy 27.75% -2.62%
MDRX Allscripts Healthcare Solutions, Inc. Buy 13.96% -5.24%
CUTR Cutera, Inc. Sell -2.29% 42.86%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.29% 3.21%
TNDM Tandem Diabetes Care, Inc. Sell -6.23% 10.65%
KIDS OrthoPediatrics Corp. Sell -6.22% 10.85%
ENTA Enanta Pharmaceuticals, Inc. Sell -6.01% 13.91%
The percentage of cash held in the portfolio is: 42.91%
New Assets Added
None
Assets Removed
Asset Action Perf %
RGEN Sell All -17.11%
VREX Sell All 13.22%
Assets Rebalanced
None
2024-11-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 10.67% 12.89%
CDMO Avid Bioservices, Inc. Buy 11.51% 15.15%
HCSG Healthcare Services Group, Inc. Buy 10.64% 8.95%
NEOG Neogen Corporation Buy 11.6% 2.09%
MGNX MacroGenics, Inc. Buy 9.63% -1.55%
ITGR Integer Holdings Corporation Buy 27.55% -1.41%
MDRX Allscripts Healthcare Solutions, Inc. Buy 13.89% -3.91%
RGEN Repligen Corporation Buy 10.96% -5.34%
CUTR Cutera, Inc. Sell -2.31% 41.07%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.22% 2.23%
TNDM Tandem Diabetes Care, Inc. Sell -6.39% 6.57%
KIDS OrthoPediatrics Corp. Sell -6.04% 11.78%
ENTA Enanta Pharmaceuticals, Inc. Sell -6.26% 8.49%
The percentage of cash held in the portfolio is: 21.79%
New Assets Added
None
Assets Removed
Asset Action Perf %
NUTX Sell All 26.23%
ALT Sell All -10.91%
Assets Rebalanced
None
2024-11-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 10.56% 15.04%
NUTX Nutex Health Inc. Buy 12.35% 31.39%
CDMO Avid Bioservices, Inc. Buy 11.43% 17.76%
HCSG Healthcare Services Group, Inc. Buy 10.56% 11.32%
NEOG Neogen Corporation Buy 11.68% 5.86%
MGNX MacroGenics, Inc. Buy 9.26% -2.58%
ITGR Integer Holdings Corporation Buy 27.3% 0.58%
MDRX Allscripts Healthcare Solutions, Inc. Buy 13.91% -0.89%
ALT Altimmune, Inc. Buy 8.22% 0.32%
RGEN Repligen Corporation Buy 11.25% 0%
CUTR Cutera, Inc. Sell -2.45% 35.71%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.08% 1.32%
TNDM Tandem Diabetes Care, Inc. Sell -6.44% 3.04%
KIDS OrthoPediatrics Corp. Sell -6.27% 5.68%
ENTA Enanta Pharmaceuticals, Inc. Sell -6.26% 5.78%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RGEN
Assets Removed
Asset Action Perf %
ARWR Sell All 11.73%
Assets Rebalanced
None
2024-11-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.91% 11.11%
VREX Varex Imaging Corporation Buy 10.63% 18.26%
NUTX Nutex Health Inc. Buy 13.93% 51.33%
CDMO Avid Bioservices, Inc. Buy 11.22% 18.05%
HCSG Healthcare Services Group, Inc. Buy 10.55% 13.61%
NEOG Neogen Corporation Buy 11.56% 6.97%
MGNX MacroGenics, Inc. Buy 9.86% 5.94%
ITGR Integer Holdings Corporation Buy 26.6% 0.1%
MDRX Allscripts Healthcare Solutions, Inc. Buy 13.57% -1.24%
ALT Altimmune, Inc. Buy 8.02% 0%
CUTR Cutera, Inc. Sell -2.6% 30.36%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.27% -3.51%
TNDM Tandem Diabetes Care, Inc. Sell -6.61% -1.63%
KIDS OrthoPediatrics Corp. Sell -6.08% 6.53%
ENTA Enanta Pharmaceuticals, Inc. Sell -6.27% 3.7%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ALT
Assets Removed
Asset Action Perf %
IOVA Sell All -12.15%
Assets Rebalanced
None
2024-11-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.24% 13.48%
VREX Varex Imaging Corporation Buy 10.94% 20.74%
NUTX Nutex Health Inc. Buy 10.44% 12.45%
CDMO Avid Bioservices, Inc. Buy 11.34% 18.24%
IOVA Iovance Biotherapeutics, Inc. Buy 8.92% -3.45%
HCSG Healthcare Services Group, Inc. Buy 10.44% 11.51%
NEOG Neogen Corporation Buy 12.46% 14.37%
MGNX MacroGenics, Inc. Buy 10.65% 13.44%
ITGR Integer Holdings Corporation Buy 27.35% 2%
MDRX Allscripts Healthcare Solutions, Inc. Buy 13.86% 0%
CUTR Cutera, Inc. Sell -2.62% 30.36%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.47% -5.38%
TNDM Tandem Diabetes Care, Inc. Sell -6.73% -2.52%
KIDS OrthoPediatrics Corp. Sell -6.38% 2.88%
ENTA Enanta Pharmaceuticals, Inc. Sell -6.45% 1.81%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MDRX
Assets Removed
Asset Action Perf %
VCEL Sell All 34.9%
Assets Rebalanced
None
2024-11-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
VCEL Vericel Corporation Buy 13.31% 28.3%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.29% 13.07%
VREX Varex Imaging Corporation Buy 10.74% 17.52%
NUTX Nutex Health Inc. Buy 11.9% 27.16%
CDMO Avid Bioservices, Inc. Buy 11.44% 18.34%
IOVA Iovance Biotherapeutics, Inc. Buy 8.94% -3.99%
HCSG Healthcare Services Group, Inc. Buy 10.24% 8.4%
NEOG Neogen Corporation Buy 12.44% 13.18%
MGNX MacroGenics, Inc. Buy 10.64% 12.4%
ITGR Integer Holdings Corporation Buy 27.04% 0%
CUTR Cutera, Inc. Sell -2.65% 30.36%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.49% -4.82%
TNDM Tandem Diabetes Care, Inc. Sell -6.62% 0%
KIDS OrthoPediatrics Corp. Sell -6.62% 0%
ENTA Enanta Pharmaceuticals, Inc. Sell -6.62% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • TNDM
  • KIDS
  • ENTA
  • ITGR
Assets Removed
Asset Action Perf %
EVH Buy All 42.39%
ARDX Sell All -16.06%
Assets Rebalanced
None
2024-11-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 12.46% 5.63%
VCEL Vericel Corporation Buy 12.47% 18.86%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.16% 10.49%
VREX Varex Imaging Corporation Buy 10.9% 17.93%
NUTX Nutex Health Inc. Buy 11.02% 16.4%
CDMO Avid Bioservices, Inc. Buy 11.55% 18.15%
IOVA Iovance Biotherapeutics, Inc. Buy 10.48% 11.33%
HCSG Healthcare Services Group, Inc. Buy 10.25% 7.31%
NEOG Neogen Corporation Buy 12.23% 10.04%
MGNX MacroGenics, Inc. Buy 11.03% 15.25%
EVH Evolent Health, Inc. Sell -4.82% -5.95%
CUTR Cutera, Inc. Sell -3.5% 8.93%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.23% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • AMPH
Assets Removed
None
Assets Rebalanced
Asset Action Weight
VCEL Buy 0.56%
NEOG Buy 0.89%
ARDX Buy 1.17%
ARWR Buy 1.45%
2024-11-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 10.71% 7.45%
VCEL Vericel Corporation Buy 10.71% 14.14%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.02% 10.23%
VREX Varex Imaging Corporation Buy 11.41% 19.42%
NUTX Nutex Health Inc. Buy 10.71% 9.47%
CDMO Avid Bioservices, Inc. Buy 10.71% 5.98%
HCSG Healthcare Services Group, Inc. Buy 10.71% 8.49%
IOVA Iovance Biotherapeutics, Inc. Buy 10.71% 10.06%
NEOG Neogen Corporation Buy 10.71% 8.93%
MGNX MacroGenics, Inc. Buy 10.71% 8.27%
EVH Evolent Health, Inc. Sell -5.03% -6.81%
CUTR Cutera, Inc. Sell -4.11% -3.57%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
SMTI Buy All -11.47%
NVCR Buy All -19.24%
Assets Rebalanced
Asset Action Weight
ARWR Sell -1.57%
VCEL Sell -1.29%
NUTX Sell -2.27%
ARDX Sell -2.9%
CDMO Sell -2.98%
HCSG Sell -6.89%
IOVA Sell -7.14%
NEOG Buy 3.21%
MGNX Buy 5.79%
2024-11-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 13.48% -2.48%
VCEL Vericel Corporation Buy 12.09% 5.42%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.88% 3.62%
VREX Varex Imaging Corporation Buy 11.41% 9.5%
NUTX Nutex Health Inc. Buy 12.01% -7.17%
CDMO Avid Bioservices, Inc. Buy 14.07% -0.19%
HCSG Healthcare Services Group, Inc. Buy 18.05% 2.01%
IOVA Iovance Biotherapeutics, Inc. Buy 18.35% 3.72%
NEOG Neogen Corporation Buy 7.56% 0.63%
MGNX MacroGenics, Inc. Buy 4.75% -4.39%
EVH Evolent Health, Inc. Sell -5.17% -0.73%
SMTI Sanara MedTech Inc. Sell -7.8% -6.02%
NVCR NovoCure Limited Sell -8.37% -9.29%
CUTR Cutera, Inc. Sell -4.33% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • CUTR
Assets Removed
None
Assets Rebalanced
Asset Action Weight
ARDX Buy 1.18%
VREX Buy 2.03%
2024-11-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 11.62% 0.83%
VCEL Vericel Corporation Buy 12.04% 4.51%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.6% 0.67%
VREX Varex Imaging Corporation Buy 9.39% 9.09%
NUTX Nutex Health Inc. Buy 11.84% -8.94%
CDMO Avid Bioservices, Inc. Buy 14.04% -0.87%
HCSG Healthcare Services Group, Inc. Buy 18.1% 1.83%
IOVA Iovance Biotherapeutics, Inc. Buy 18.04% 1.45%
NEOG Neogen Corporation Buy 7.6% 0.7%
MGNX MacroGenics, Inc. Buy 4.99% 0%
EVH Evolent Health, Inc. Sell -5.22% -1.16%
SMTI Sanara MedTech Inc. Sell -7.85% -6.21%
NVCR NovoCure Limited Sell -8.2% -6.59%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MGNX
Assets Removed
Asset Action Perf %
CUTR Buy All 21.33%
FATE Buy All 24.3%
IRWD Sell All -1.64%
Assets Rebalanced
None
2024-11-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 13.27% -7.28%
ARDX Ardelyx, Inc. Buy 11.52% -2.81%
VCEL Vericel Corporation Buy 12.4% 4.63%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.77% -0.67%
VREX Varex Imaging Corporation Buy 9.6% 8.51%
NUTX Nutex Health Inc. Buy 12.01% -10.19%
CDMO Avid Bioservices, Inc. Buy 14% -3.86%
HCSG Healthcare Services Group, Inc. Buy 18.31% 0.18%
IOVA Iovance Biotherapeutics, Inc. Buy 17.3% -5.35%
NEOG Neogen Corporation Buy 7.73% -0.42%
CUTR Cutera, Inc. Sell -4.51% 22.67%
FATE Fate Therapeutics, Inc. Sell -4.3% 26.17%
EVH Evolent Health, Inc. Sell -5.34% -0.69%
SMTI Sanara MedTech Inc. Sell -7.95% -4.6%
NVCR NovoCure Limited Sell -7.91% 0%
The percentage of cash held in the portfolio is: 2.1%
New Assets Added
  • NVCR
Assets Removed
Asset Action Perf %
ORMP Buy All 0.42%
Assets Rebalanced
Asset Action Weight
CDMO Buy 0.85%
2024-10-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 13.96% -0.23%
ARDX Ardelyx, Inc. Buy 11.52% -0.5%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.95% 3.2%
VCEL Vericel Corporation Buy 12.61% 8.89%
VREX Varex Imaging Corporation Buy 9.51% 10%
NUTX Nutex Health Inc. Buy 11.63% -10.96%
CDMO Avid Bioservices, Inc. Buy 11.94% -1.74%
HCSG Healthcare Services Group, Inc. Buy 17.98% 0.64%
IOVA Iovance Biotherapeutics, Inc. Buy 17.51% -1.99%
NEOG Neogen Corporation Buy 7.59% 0%
CUTR Cutera, Inc. Sell -5.09% 10.67%
FATE Fate Therapeutics, Inc. Sell -4.83% 15.26%
ORMP Oramed Pharmaceuticals Inc. Sell -5.46% 4.18%
EVH Evolent Health, Inc. Sell -5.2% -0.34%
SMTI Sanara MedTech Inc. Sell -7.63% -2.69%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NEOG
Assets Removed
Asset Action Perf %
NKTR Sell All -12.41%
Assets Rebalanced
None
2024-10-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 13.55% -2.58%
ARDX Ardelyx, Inc. Buy 11.25% -2.32%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12% 4.24%
VCEL Vericel Corporation Buy 12.49% 8.48%
VREX Varex Imaging Corporation Buy 9.34% 8.68%
NKTR Nektar Therapeutics Buy 8.06% -6.21%
NUTX Nutex Health Inc. Buy 12.56% -3.3%
CDMO Avid Bioservices, Inc. Buy 11.77% -2.51%
HCSG Healthcare Services Group, Inc. Buy 17.76% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 17.76% 0%
CUTR Cutera, Inc. Sell -5.06% 10.67%
FATE Fate Therapeutics, Inc. Sell -5.06% 10.59%
ORMP Oramed Pharmaceuticals Inc. Sell -5.5% 2.93%
EVH Evolent Health, Inc. Sell -5.24% -1.81%
SMTI Sanara MedTech Inc. Sell -7.69% -4.15%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HCSG
  • IOVA
Assets Removed
Asset Action Perf %
SGMO Sell All 110.31%
Assets Rebalanced
None
2024-10-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 13.98% -7.04%
ARDX Ardelyx, Inc. Buy 11.9% -4.47%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12.93% 3.82%
VCEL Vericel Corporation Buy 12.94% 3.94%
SGMO Sangamo Therapeutics, Inc. Buy 19.24% 54.64%
VREX Varex Imaging Corporation Buy 9.92% 6.69%
NKTR Nektar Therapeutics Buy 8.47% -8.97%
NUTX Nutex Health Inc. Buy 13.75% -2.14%
CDMO Avid Bioservices, Inc. Buy 12.61% -3.47%
CUTR Cutera, Inc. Sell -5.23% 14.67%
FATE Fate Therapeutics, Inc. Sell -5.06% 17.45%
ORMP Oramed Pharmaceuticals Inc. Sell -6.07% 0.84%
EVH Evolent Health, Inc. Sell -5.77% -3.58%
SMTI Sanara MedTech Inc. Sell -8.02% -0.48%
The percentage of cash held in the portfolio is: 14.41%
New Assets Added
None
Assets Removed
Asset Action Perf %
ORGO Sell All -9.09%
Assets Rebalanced
None
2024-10-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 13.98% -6.57%
ORGO Organogenesis Holdings Inc. Buy 11.62% -6.82%
ARDX Ardelyx, Inc. Buy 12.01% -2.98%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12.74% 2.94%
VCEL Vericel Corporation Buy 12.61% 1.85%
SGMO Sangamo Therapeutics, Inc. Buy 19.01% 53.61%
VREX Varex Imaging Corporation Buy 9.8% 5.95%
NKTR Nektar Therapeutics Buy 8.61% -6.9%
NUTX Nutex Health Inc. Buy 13.83% -0.97%
CDMO Avid Bioservices, Inc. Buy 12.8% -1.45%
CUTR Cutera, Inc. Sell -5.28% 13.33%
FATE Fate Therapeutics, Inc. Sell -5.33% 12.46%
ORMP Oramed Pharmaceuticals Inc. Sell -6.01% 1.26%
EVH Evolent Health, Inc. Sell -5.44% 1.81%
SMTI Sanara MedTech Inc. Sell -7.94% 0%
The percentage of cash held in the portfolio is: 2.99%
New Assets Added
  • SMTI
Assets Removed
None
Assets Rebalanced
Asset Action Weight
NUTX Buy 1.12%
IRWD Buy 1.79%
CDMO Buy 1.83%
2024-10-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.06% -6.57%
ORGO Organogenesis Holdings Inc. Buy 11.76% -6.17%
ARDX Ardelyx, Inc. Buy 11.49% -7.62%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12.8% 2.89%
VCEL Vericel Corporation Buy 12.49% 0.45%
SGMO Sangamo Therapeutics, Inc. Buy 19.74% 58.76%
VREX Varex Imaging Corporation Buy 9.79% 5.37%
NKTR Nektar Therapeutics Buy 9.03% -2.76%
NUTX Nutex Health Inc. Buy 11.28% -4.88%
CDMO Avid Bioservices, Inc. Buy 11.19% 0%
CUTR Cutera, Inc. Sell -5.38% 12%
FATE Fate Therapeutics, Inc. Sell -5.77% 5.61%
ORMP Oramed Pharmaceuticals Inc. Sell -6.09% 0.42%
EVH Evolent Health, Inc. Sell -5.38% 3.41%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • CDMO
Assets Removed
Asset Action Perf %
CDXS Sell All -9.73%
Assets Rebalanced
None
2024-10-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.55% -4.23%
ORGO Organogenesis Holdings Inc. Buy 12.84% 0.65%
ARDX Ardelyx, Inc. Buy 12.12% -4.3%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.33% 5.27%
VCEL Vericel Corporation Buy 12.58% -0.62%
CDXS Codexis, Inc. Buy 12.32% -2.65%
SGMO Sangamo Therapeutics, Inc. Buy 15.79% 24.74%
VREX Varex Imaging Corporation Buy 9.8% 3.64%
NKTR Nektar Therapeutics Buy 9.39% -0.69%
NUTX Nutex Health Inc. Buy 12.07% 0%
CUTR Cutera, Inc. Sell -5.8% 6.8%
FATE Fate Therapeutics, Inc. Sell -6.19% 0.62%
ORMP Oramed Pharmaceuticals Inc. Sell -6.18% 0.84%
EVH Evolent Health, Inc. Sell -5.61% 0.99%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NUTX
Assets Removed
Asset Action Perf %
IRTC Buy All -20.54%
Assets Rebalanced
None
2024-10-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.16% -1.64%
ORGO Organogenesis Holdings Inc. Buy 13.22% 0.97%
ARDX Ardelyx, Inc. Buy 12.65% -2.65%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.75% 5.84%
VCEL Vericel Corporation Buy 12.71% -2.16%
CDXS Codexis, Inc. Buy 12.6% -2.95%
SGMO Sangamo Therapeutics, Inc. Buy 12.18% -6.19%
VREX Varex Imaging Corporation Buy 10.1% 4.13%
NKTR Nektar Therapeutics Buy 9.3% -4.14%
CUTR Cutera, Inc. Sell -5.96% 6.67%
FATE Fate Therapeutics, Inc. Sell -6.27% 1.87%
ORMP Oramed Pharmaceuticals Inc. Sell -6.28% 1.67%
IRTC iRhythm Technologies, Inc. Sell -5.67% 0.97%
EVH Evolent Health, Inc. Sell -5.81% 0%
The percentage of cash held in the portfolio is: 21.34%
New Assets Added
  • EVH
Assets Removed
Asset Action Perf %
BKD Sell All 3.8%
Assets Rebalanced
None
2024-10-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.64% 4.23%
ORGO Organogenesis Holdings Inc. Buy 12.79% -0.32%
ARDX Ardelyx, Inc. Buy 12.3% -3.48%
BKD Brookdale Senior Living Inc. Buy 13.92% 9.26%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.71% 7.64%
VCEL Vericel Corporation Buy 12.31% -3.37%
CDXS Codexis, Inc. Buy 12.66% -0.59%
SGMO Sangamo Therapeutics, Inc. Buy 12.34% -3.09%
VREX Varex Imaging Corporation Buy 9.51% 0%
NKTR Nektar Therapeutics Buy 9.51% 0%
CUTR Cutera, Inc. Sell -5.51% 12%
FATE Fate Therapeutics, Inc. Sell -6.28% -0.31%
ORMP Oramed Pharmaceuticals Inc. Sell -6.29% -0.42%
IRTC iRhythm Technologies, Inc. Sell -5.6% 0.35%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • VREX
  • NKTR
Assets Removed
Asset Action Perf %
AXSM Buy All -7.81%
RDNT Sell All -3.2%
Assets Rebalanced
None
2024-10-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.36% 3.05%
ORGO Organogenesis Holdings Inc. Buy 13.19% 3.9%
ARDX Ardelyx, Inc. Buy 12.46% -1.16%
BKD Brookdale Senior Living Inc. Buy 12.64% 0.33%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12.94% 2.69%
VCEL Vericel Corporation Buy 12.56% -0.33%
RDNT RadNet, Inc. Buy 12.63% 0.2%
CDXS Codexis, Inc. Buy 12.59% 0%
SGMO Sangamo Therapeutics, Inc. Buy 12.59% 0%
CUTR Cutera, Inc. Sell -5.7% 8%
FATE Fate Therapeutics, Inc. Sell -5.89% 4.98%
ORMP Oramed Pharmaceuticals Inc. Sell -6.09% 1.67%
IRTC iRhythm Technologies, Inc. Sell -5.33% 4.11%
AXSM Axsome Therapeutics, Inc. Sell -5.55% 0.18%
The percentage of cash held in the portfolio is: 14.59%
New Assets Added
  • CDXS
  • SGMO
Assets Removed
None
Assets Rebalanced
None
2024-10-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.21% 0.7%
ORGO Organogenesis Holdings Inc. Buy 12.87% 0.32%
ARDX Ardelyx, Inc. Buy 12.63% -0.83%
BKD Brookdale Senior Living Inc. Buy 12.73% 0%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12.73% 0%
VCEL Vericel Corporation Buy 12.73% 0%
RDNT RadNet, Inc. Buy 12.73% 0%
CUTR Cutera, Inc. Sell -5.93% 5.33%
FATE Fate Therapeutics, Inc. Sell -5.95% 4.98%
ORMP Oramed Pharmaceuticals Inc. Sell -6.24% 0.42%
IRTC iRhythm Technologies, Inc. Sell -5.19% 7.61%
AXSM Axsome Therapeutics, Inc. Sell -5.54% 1.35%
The percentage of cash held in the portfolio is: 40.2%
New Assets Added
  • BKD
  • ARWR
  • VCEL
  • RDNT
Assets Removed
None
Assets Rebalanced
None
2024-10-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.2% 0%
ORGO Organogenesis Holdings Inc. Buy 12.87% -0.32%
ARDX Ardelyx, Inc. Buy 12.81% 0%
CUTR Cutera, Inc. Sell -6.39% -1.33%
FATE Fate Therapeutics, Inc. Sell -6.07% 3.74%
ORMP Oramed Pharmaceuticals Inc. Sell -6.28% 0.42%
IRTC iRhythm Technologies, Inc. Sell -5.14% 8.99%
AXSM Axsome Therapeutics, Inc. Sell -5.71% -1.12%
The percentage of cash held in the portfolio is: 91.7%
New Assets Added
  • ARDX
Assets Removed
None
Assets Rebalanced
None
2024-10-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.01% -1.17%
ORGO Organogenesis Holdings Inc. Buy 12.61% -1.95%
CUTR Cutera, Inc. Sell -6.11% 2.67%
FATE Fate Therapeutics, Inc. Sell -5.75% 8.41%
ORMP Oramed Pharmaceuticals Inc. Sell -6.3% -0.42%
IRTC iRhythm Technologies, Inc. Sell -5.15% 8.5%
AXSM Axsome Therapeutics, Inc. Sell -5.4% 4.05%
The percentage of cash held in the portfolio is: 104.09%
New Assets Added
None
Assets Removed
Asset Action Perf %
BCRX Sell All -6.07%
Assets Rebalanced
None
2024-10-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.26% 0.94%
BCRX BioCryst Pharmaceuticals, Inc. Buy 12.86% 0%
ORGO Organogenesis Holdings Inc. Buy 12.86% 0%
CUTR Cutera, Inc. Sell -6.28% 0%
FATE Fate Therapeutics, Inc. Sell -6.3% -0.31%
ORMP Oramed Pharmaceuticals Inc. Sell -6.17% 1.67%
IRTC iRhythm Technologies, Inc. Sell -5.63% 0%
AXSM Axsome Therapeutics, Inc. Sell -5.63% 0%
The percentage of cash held in the portfolio is: 92.02%
New Assets Added
  • IRTC
  • AXSM
  • BCRX
  • ORGO
Assets Removed
Asset Action Perf %
CERS Buy All 19.43%
Assets Rebalanced
None
2024-10-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.17% 0%
CERS Cerus Corporation Sell -4.85% 19.91%
CUTR Cutera, Inc. Sell -6.29% 0%
FATE Fate Therapeutics, Inc. Sell -6.29% 0%
ORMP Oramed Pharmaceuticals Inc. Sell -6.29% 0%
The percentage of cash held in the portfolio is: 111.54%
New Assets Added
  • CUTR
  • FATE
  • ORMP
  • IRWD
Assets Removed
None
Assets Rebalanced
None
2024-10-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
CERS Cerus Corporation Sell -5% 17.54%
The percentage of cash held in the portfolio is: 105%
New Assets Added
None
Assets Removed
Asset Action Perf %
VREX Buy All -1.88%
Assets Rebalanced
None
2024-09-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Sell -6.18% -1.88%
CERS Cerus Corporation Sell -5.03% 17.06%
The percentage of cash held in the portfolio is: 111.21%
New Assets Added
None
Assets Removed
Asset Action Perf %
AVXL Buy All 3.4%
PODD Sell All 13.51%
Assets Rebalanced
None
2024-09-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 23.45% 15.17%
AVXL Anavex Life Sciences Corp. Sell -5.93% 3.57%
VREX Varex Imaging Corporation Sell -6.1% -0.85%
CERS Cerus Corporation Sell -5.1% 15.64%
The percentage of cash held in the portfolio is: 93.68%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Buy All -4.63%
Assets Rebalanced
None
2024-09-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 23.49% 16.82%
STAA STAAR Surgical Company Sell -6.2% 4.11%
AVXL Anavex Life Sciences Corp. Sell -5.63% 7.31%
VREX Varex Imaging Corporation Sell -5.93% 0.6%
CERS Cerus Corporation Sell -5.01% 16.11%
The percentage of cash held in the portfolio is: 99.29%
New Assets Added
None
Assets Removed
Asset Action Perf %
AADI Sell All 8.57%
NVCR Sell All -11.63%
Assets Rebalanced
None
2024-09-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 13.29% 8%
PODD Insulet Corporation Buy 23.44% 16.92%
NVCR NovoCure Limited Buy 18.46% -8.98%
STAA STAAR Surgical Company Sell -6.43% 0.25%
AVXL Anavex Life Sciences Corp. Sell -5.73% 5.44%
VREX Varex Imaging Corporation Sell -5.64% 5.21%
CERS Cerus Corporation Sell -5.08% 14.69%
The percentage of cash held in the portfolio is: 67.69%
New Assets Added
None
Assets Removed
Asset Action Perf %
MYGN Sell All -1.56%
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings